AI technologies for drug discovery and development
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
443
NCT03194217
BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 10, 2017
Completion: May 28, 2019
NCT04737304
A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis
Phase: Phase 1/2
Start: Oct 14, 2020
Completion: Jan 26, 2023
NCT06118385
Study Investigating the Safety, Tolerability, PK and Food Effect of BEN8744.
Phase: Phase 1
Start: Aug 30, 2023
Completion: Mar 18, 2024
Loading map...